Company Filing History:
Years Active: 2018-2025
Title: Cornelia Brünn: Innovator in Neurotoxin Research
Introduction
Cornelia Brünn is a notable inventor based in Frankfurt-am-Main, Germany. He has made significant contributions to the field of neurotoxin research, holding a total of 3 patents. His work focuses on methods for determining the biological activity of neurotoxin polypeptides in cells, which has important implications for medical research and treatment.
Latest Patents
Brünn's latest patents include innovative methods for directly determining the biological activity of neurotoxin polypeptides in cells. The patented methods involve a series of steps, including incubating susceptible cells with neurotoxin polypeptides, fixing and optionally permeabilizing the cells, and using specific capture and detection antibodies to measure the biological activity of the neurotoxin. These methods not only enhance the understanding of neurotoxin effects but also provide a kit for practical application in research settings.
Career Highlights
Cornelia Brünn is currently associated with Merz Pharma GmbH & Co. KGaA, where he continues to advance his research in neurotoxin activity. His work has been instrumental in developing techniques that can be utilized in various biomedical applications.
Collaborations
Brünn has collaborated with notable colleagues, including Michael Pfeil and Josef Friedrich, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Cornelia Brünn's contributions to neurotoxin research exemplify the impact of innovative methods in understanding biological activity. His patents and ongoing work at Merz Pharma highlight the importance of research in advancing medical science.